When was Techcyte founded?

Techcyte was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Techcyte located?

Techcyte is headquartered in Orem, United States. It is registered at 105 S. State Street #401, Orem, UT 84058, US.

How many employees does Techcyte have?

As of Jun 30, 2026, the latest employee count at Techcyte is 119.

Is Techcyte a funded company?

Techcyte is a funded company, having raised a total of $50.4M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2016.

When was the latest funding round of Techcyte?

Techcyte's latest funding was a $***** Series B round on Apr 30, 2026, with participation from 2 investors.

Where does Techcyte rank among its competitors?

Techcyte ranks 7th amongst 291 active competitors, of which 86 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of Techcyte?

Techcyte's top competitors include PAIGE, PathAI and Deciphex. Among them, Techcyte secured the most recent funding round in April, 2026.

Techcyte - 2026 Company Profile, Team, Funding & Competitors

Techcyte is a series B company based in Orem (United States), founded in 2014 by Ralph Yarro. It operates as an Artificial intelligence (AI) based image analysis platform for pathologists. Techcyte has raised $50.4M in funding from Zoetis and ARUP Laboratories. The company has 291 active competitors, including 86 funded and 16 that have exited. Its top competitors include companies like PAIGE, PathAI and Deciphex.

Company Details

Artificial intelligence (AI) based image analysis platform for pathologists. The tool called Techcyte uses several Artificial intelligence (AI) platforms to perform image analysis on digital microscopy images. Also developing AI-based digital analysis tools for hematology tests, cervical cytology tests, ova and parasites (O&P) fecal tests for humans as well as animal samples. The company has collaborated with Motic, a leading provider of whole slide scanners to provide advanced solutions for scanning, image analysis, workflow, and reporting recently.

Website: techcyte.com
Social
Email ID: *****@techcyte.com
Phone Number: +1 **********
Registered Address: 105 S. State Street #401, Orem, UT 84058, US

Key Metrics

Founded Year

2014

Location

Orem, United States

Stage

Series B

Total Funding

$50.4M in 5 rounds

Latest Funding Round

Series B, Apr 30, 2026, $*****

Investors

Zoetis & 3 more

Ranked

7^th among 291 active competitors

Employee Count

119 as on Jun 30, 2026

Similar Companies

OpenEvidence & 2621 more

View Techcyte's full profile

Techcyte is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Techcyte, Inc. CIN: 20241608097 , United States, Active	Jun 03, 2024	-	-	-

Techcyte has raised a total funding of $50.4M over 5 rounds. Its first funding round was on 2016. Its latest funding round was a Series B round on Apr 30, 2026 for $*****. 2 investors participated in its latest round. Techcyte has 4 institutional investors.

Here is the list of recent funding rounds of Techcyte:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 30, 2026	8127375	Series B	9858819	4975562	6216904	1543548
Dec 22, 2023	1988041	Series B	5983388	8471514	5899322	3498060
Aug 19, 2021	8021007	Series B	6311347	7932195	Zoetis & 1 more	7652324

Access funding benchmarks and valuations. Sign up today!

View details of Techcyte's funding rounds and investors

The founders of Techcyte is Ralph Yarro.

Here are the details of Techcyte's key team members:

Ralph Yarro: Founder & CEO of Techcyte and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 2 email addresses

Techcyte's Board of Directors

Techcyte's board has 10 active members. Richard Smith, Ralph Yarro, Kyle Wilson, Kent Gordon, Michael Aicher, Ben Cahoon, Mohammed Salama, Michael Wolfgramm, William Dorsey and Jay Tolley are independent board members.

Here is the list of Techcyte's board of directors:

Name	Type	Representing	Status	Duration
Richard Smith	Independent board member	-	Current	4y 11m
lnx{krq	Independent board member	-	Current	3y 9m
ihgewgf	Independent board member	-	Current	8y 1m
guunbgk	Independent board member	-	Current	9y 2m
azhayyz	Independent board member	-	Current	2y 3m
grsqewn	Independent board member	-	Current	5y 3m
tshpxyk	Independent board member	-	Current	5y 4m
kqgbuyo	Independent board member	-	Current	7y 6m
rgajx{m	Independent board member	-	Current	8y 6m
qyfcojk	Independent board member	-	Current	7y 4m

View details of Techcyte's Founder profiles and Board Members

Techcyte's employee count trend

Techcyte has 119 employees as of Jun 26. Here is Techcyte's employee count trend over the years:

Uncover Techcyte's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Techcyte include PAIGE, PathAI and Deciphex. Here is the list of Top 10 competitors of Techcyte, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	71/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Tiger Global Management ... & 22 others	71/100
3rd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
4th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Boehringer Ingelheim Venture Fund, Wellington Partners Venture Capital ... & 9 others	64/100
5th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
6th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
7th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	Atua Ventures, Mayo Clinic & 2 others	61/100
8th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	61/100
9th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
10th	Enspectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Tao Capital Partners & 6 others	59/100